Trial · NCT01510769
Adverse events135
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 135
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dental caries | Gastrointestinal disorders | Lesinurad 200 mg + Febuxostat | 0 | 106 | 0 |
| other | Dental caries | Gastrointestinal disorders | Lesinurad 400 mg + Febuxostat | 3 | 109 | 3 |
| other | Dental caries | Gastrointestinal disorders | Placebo + Febuxostat | 0 | 109 | 0 |
| other | Toothache | Gastrointestinal disorders | Lesinurad 200 mg + Febuxostat | 1 | 106 | 1 |
| other | Toothache | Gastrointestinal disorders | Lesinurad 400 mg + Febuxostat | 3 | 109 | 3 |
| other | Toothache | Gastrointestinal disorders | Placebo + Febuxostat | 0 | 109 | 0 |
| other | Non-cardiac chest pain | General disorders | Lesinurad 200 mg + Febuxostat | 1 | 106 | 1 |
| other | Non-cardiac chest pain | General disorders | Lesinurad 400 mg + Febuxostat | 3 | 109 | 4 |
| other | Non-cardiac chest pain | General disorders | Placebo + Febuxostat | 0 | 109 | 0 |
| other | Pyrexia | General disorders | Lesinurad 200 mg + Febuxostat | 1 | 106 | 1 |
| other | Pyrexia | General disorders | Lesinurad 400 mg + Febuxostat | 7 | 109 | 7 |
| other | Pyrexia | General disorders | Placebo + Febuxostat | 4 | 109 | 4 |
| other | Influenza | Infections and infestations | Lesinurad 200 mg + Febuxostat | 6 | 106 | 6 |
| other | Influenza | Infections and infestations | Lesinurad 400 mg + Febuxostat | 2 | 109 | 4 |
| other | Influenza | Infections and infestations | Placebo + Febuxostat | 2 | 109 | 2 |
| other | Nasopharyngitis | Infections and infestations | Lesinurad 200 mg + Febuxostat | 10 | 106 | 10 |
| other | Nasopharyngitis | Infections and infestations | Lesinurad 400 mg + Febuxostat | 15 | 109 | 15 |
| other | Nasopharyngitis | Infections and infestations | Placebo + Febuxostat | 9 | 109 | 12 |
| other | Contusion | Injury, poisoning and procedural complications | Lesinurad 200 mg + Febuxostat | 2 | 106 | 2 |
| other | Contusion | Injury, poisoning and procedural complications | Lesinurad 400 mg + Febuxostat | 7 | 109 | 9 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01510769/events